| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |